South Korean digital therapeutics startup Nunaps has closed a W5bn (US$4.2m) Series A funding led by Company K Partners, KTB Network, and K2 Investment Partners. “Nunaps is Korea’s first digital therapeutics company and has great potential to become a global top-tier, setting up clinical trials for new digital therapeutics that employs AI technologies to address…
©2022 All rights reserved LaingBuisson 
 Series A funding led by Company K Partners, KTB Network, and K2 Investment Partners.){kind=link}